
Altimmune (ALT) Earnings Dates & Reports
Altimmune (ALT) Most Recent Earnings
Report DateMay 13, 2025
Period EndingQ1 2025
Est. EPS-$0.35
Actual EPS-$0.26
EarningsBeat
Altimmune (ALT) Earnings
View the latest Altimmune (ALT) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Altimmune (ALT)
Order type
Buy in
Order amount
Est. shares
0 shares
Altimmune (ALT) Earnings per Share (EPS) History
Signup for full accessBrowse free
Altimmune (ALT) Latest Earnings
The value each ALT share was expected to gain vs. the value each share gained.
Altimmune (ALT) reported its most recent earnings on May 13, 2025 for Q1 2025, posting earnings per share (EPS) of -$0.26. This exceeded analysts' expectations of -$0.35 by 25.71%, marking a Beat.
For comparison, Altimmune reported EPS of -$0.34 in the same quarter last year.
The company is expected to announce its next earnings report on 08/07/2025, with analysts projecting an EPS of -$0.30.
Altimmune (ALT) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2025Aug 7, 2025 | -$0.30 | Next earnings call Aug. 7, 2025 | ||
Q1 2025May 13, 2025 | -$0.35 | -$0.26 | -25.71% | |
Q4 2024Feb 27, 2025 | -$0.34 | -$0.33 | -2.94% | |
Q3 2024Nov 12, 2024 | -$0.35 | -$0.32 | -8.57% | |
Q2 2024Aug 8, 2024 | -$0.34 | -$0.35 | +2.94% | |
Altimmune (ALT) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Altimmune’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 13, 2025 | — | — | — |
Feb 27, 2025 | — | — | — |
Nov 12, 2024 | — | — | — |
Aug 8, 2024 | — | — | — |
Altimmune (ALT) Earnings FAQs
Altimmune (ALT) last reported earnings on May 13, 2025 for Q1 2025, posting an EPS of -$0.26, which Beat the estimate of -$0.35 by 25.71%.
For Q1 2025, Altimmune (ALT) reported an EPS of -$0.26, exceeding analysts' estimate of -$0.35 by 25.71%.
For Q1 2025, Altimmune (ALT) Beat expectations with an actual EPS of -$0.26 vs. an estimated EPS of -$0.35.
Following the last earnings report on May 13, 2025, Altimmune (ALT)'s stock price moved — from — to —.
The next Altimmune (ALT) earnings call is scheduled for Aug. 7, 2025, where executives will discuss financial results and outlook.